Gemlapodect (NOE-105)

NOE-105 · Noema Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemlapodect (NOE-105), covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome [Phase 2]